Clinical Trials Browser

Phase 1/2 × pazopanib × Genitourinary × Clear all

NCT01684397 2026-02-27

Pazopanib Hydrochloride and Bevacizumab in Treating Patients With Previously Untreated Metastatic Kidney Cancer

Phase 1/2 Active not recruiting

Carcinoma, Renal Cell

NCT01265940 2012-10-10

Pazopanib and Vinflunine in Urothelial Cancer of the Bladder

Phase 1/2 Completed

Urinary Bladder Neoplasms